Accuray Incorporated (ARAY)
| Market Cap | 465.51M |
| Revenue (ttm) | 418.40M |
| Net Income (ttm) | -7.74M |
| Shares Out | 90.92M |
| EPS (ttm) | -0.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,802,092 |
| Open | 5.71 |
| Previous Close | 5.29 |
| Day's Range | 4.93 - 5.18 |
| 52-Week Range | 3.46 - 6.02 |
| Beta | 1.87 |
| Analysts | Strong Buy |
| Price Target | 8.50 (+66.0%) |
| Earnings Date | Nov 3, 2021 |
About ARAY
Accuray Incorporated develops, manufactures, and sells radiotherapy systems for alternative cancer treatments in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact Sy...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Accuray stock is "Strong Buy." The 12-month stock price forecast is 8.50, which is an increase of 66.02% from the latest price.
News
After Golden Cross, Accuray (ARAY)'s Technical Outlook is Bright
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Earnings Estimates Rising for Accuray (ARAY): Will It Gain?
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's What Could Help Accuray (ARAY) Maintain Its Recent Price Strength
If you are looking for stocks that are well positioned to maintain their recent uptrend, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Str...
Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively T...
SUNNYVALE, Calif., Nov. 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that more than two decades of globally-driven clinical data support the use of the company's CyberKni...
Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
SUNNYVALE, Calif., Nov. 9, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in Stifel's 2021 Virtual Healthcare Conference.
3 Penny Stocks To Add to Your Watchlist This Month November
Are these penny stocks on your watchlist? The post 3 Penny Stocks To Add to Your Watchlist This Month November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Accuray (ARAY) Q1 Earnings Beat Estimates, Margins Down
Accuray (ARAY) registers growth in both Service and Product revenues during fiscal Q1.
Accuray Reports Fiscal 2022 First Quarter Financial Results
SUNNYVALE, Calif., Nov. 3, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2022 ended September 30, 2021.
Accuray CyberKnife® Robotic Radiotherapy Platform Could Significantly Improve Survival in Early-Stage Breast Cancer P...
SUNNYVALE, Calif., Oct. 25, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that a study published in Frontiers in Oncology found early-stage breast cancer patients could exper...
Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range b...
SUNNYVALE, Calif., Oct. 21, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), today announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021.
Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021
SUNNYVALE, Calif., Oct. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is showcasing its new VOLO™ Ultra for the Radixact ® System, at ASTRO 2021.
Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021
SUNNYVALE, Calif., Oct. 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021, after the market c...
Accuray (ARAY), C-RAD Ink Deal to Enhance Breast Cancer Treatment
Accuray's (ARAY) latest agreement is likely to improve breast cancer treatment.
Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021
SUNNYVALE, Calif., Oct. 12, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host an Analyst & Investor Meeting on Monday, October 25, 2021, in conjunction ...
Accuray's (ARAY) Radiotherapy Technologies Adopted by Unicancer
Accuray's (ARAY) proprietary radiotherapy technologies get selected by Unicancer, which is the largest network of comprehensive cancer centers in Europe.
C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities
UPPSALA, Sweden, and SUNNYVALE, Calif., Oct. 4, 2021 /PRNewswire/ -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to...
French Hospital Network Unicancer Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT...
SUNNYVALE, Calif., Sept. 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Unicancer has selected three Radixact ® Systems with the ClearRT ™ helical fan-beam kVCT imagi...
Nagoya City University Hospital is First in Japan to Treat Cancer Patients Using the Accuray Radixact® System with Cl...
SUNNYVALE, Calif., Sept. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Nagoya City University Hospital in Aichi has treated the first cancer patient in Japan usin...
Accuray's (ARAY) CyberKnife Favored For Prostate Cancer Treatment
Per the PACE trial data, patients treated with Accuray's (ARAY) CyberKnife SBRT are likely to experience lesser bladder-related side effects unlike conventional linear accelerator.
Accuray CyberKnife® Robotic Radiotherapy Platform is Superior to Conventional Linear Accelerators in Reducing Inciden...
SUNNYVALE, Calif., Sept. 14, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the PACE – Prostate Advances in Comparative Evidence – trial indicate the company's C...
Why Is Accuray (ARAY) Down 3.4% Since Last Earnings Report?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
Mika Nishimura Joins Accuray Board of Directors
SUNNYVALE, Calif., Aug. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021.
Accuray (ARAY) Posts In-Line Q4 Earnings, Beats on Revenues
Accuray (ARAY) registers growth in Service and Product revenues during fiscal Q4.
Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates
Accuray (ARAY) delivered earnings and revenue surprises of 0.00% and 9.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results
SUNNYVALE, Calif., Aug. 11, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2021.